K. Khunti

First name
K.
Last name
Khunti
Cavender, M. A., Norhammar, A., Birkeland, K. I., Jorgensen, M. E., Wilding, J. P., Khunti, K., et al. (2018). SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL. J Am Coll Cardiol. http://doi.org/10.1016/j.jacc.2018.01.085
View
Wilding, J., Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., et al. (2018). Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink. BMC Med. http://doi.org/10.1186/s12916-018-1085-8
View
Khunti, K., Danese, M. D., Kutikova, L., Catterick, D., Sorio-Vilela, F., Gleeson, M., et al. (2018). Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe. JAMA Netw Open. http://doi.org/10.1001/jamanetworkopen.2018.5554
View
Spanopoulos, D., Okhai, H., Zaccardi, F., Tebboth, A., Barrett, B., Busse, M., et al. (2019). Temporal variation of renal function in people with type 2 diabetes mellitus: a retrospective UK Clinical Practice Research Datalink cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.13734
View
Zaccardi, F., Husemoen, L. L. N., Thorsted, B. L., Webb, D. R., Paul, S. K., Davies, M. J., & Khunti, K. (2019). Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: An observational study. Nutr Metab Cardiovasc Dis. http://doi.org/10.1016/j.numecd.2019.01.006
View
Lawson, C. A., Zaccardi, F., Squire, I., Ling, S., Davies, M. J., Lam, C. S. P., et al. (2019). 20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study. Lancet Public Health. http://doi.org/10.1016/s2468-2667(19)30108-2
View
Minhas, J. S., Coles, B., Mistri, A. K., Eveson, D. J., Hussain, S. T., Potter, J. F., et al. (2020). What is the optimal blood pressure level for patients with atrial fibrillation treated with direct oral anticoagulants?. J Hypertens. http://doi.org/10.1097/hjh.0000000000002487
View
Lawson, C. A., Zaccardi, F., Squire, I., Okhai, H., Davies, M., Huang, W., et al. (2020). Risk Factors for Heart Failure: 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity. Circ Heart Fail. http://doi.org/10.1161/circheartfailure.119.006472
View
Zaccardi, F., Ling, S., Lawson, C., Davies, M. J., & Khunti, K. (2020). Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study. Diabetologia. http://doi.org/10.1007/s00125-020-05223-3
View
Coles, B., Khunti, K., Booth, S., Zaccardi, F., Davies, M. J., & Gray, L. J. (2020). Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data. BMJ Open. http://doi.org/10.1136/bmjopen-2020-037937
View